These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression? Jakovljević M Psychiatr Danub; 2011 Mar; 23(1):2-9. PubMed ID: 21448091 [TBL] [Abstract][Full Text] [Related]
11. Emerging targets for the pharmacological treatment of depression: focus on melatonergic system. Catena-Dell'Osso M; Marazziti D; Rotella F; Bellantuono C Curr Med Chem; 2012; 19(3):428-37. PubMed ID: 22335516 [TBL] [Abstract][Full Text] [Related]
13. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action. Kasper S; Hamon M World J Biol Psychiatry; 2009; 10(2):117-26. PubMed ID: 19255935 [TBL] [Abstract][Full Text] [Related]
14. [Modern approaches to the synchronization of circadian rhythms in treatment of depression]. Barylnik JB; Filippova NV; Trayber LV Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):124-8. PubMed ID: 25629135 [TBL] [Abstract][Full Text] [Related]
15. Disturbances of diurnal phase markers, behavior, and clock genes in a rat model of depression; modulatory effects of agomelatine treatment. Højgaard K; Christiansen SL; Bouzinova EV; Wiborg O Psychopharmacology (Berl); 2018 Mar; 235(3):627-640. PubMed ID: 29151193 [TBL] [Abstract][Full Text] [Related]
16. [Agomelatine: the first "melatoninergic" antidepressant]. Bánki MC Neuropsychopharmacol Hung; 2006 Oct; 8(3):105-12. PubMed ID: 17211046 [TBL] [Abstract][Full Text] [Related]
18. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Pandi-Perumal SR; Moscovitch A; Srinivasan V; Spence DW; Cardinali DP; Brown GM Prog Neurobiol; 2009 Aug; 88(4):264-71. PubMed ID: 19454302 [TBL] [Abstract][Full Text] [Related]
19. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. de Bodinat C; Guardiola-Lemaitre B; Mocaër E; Renard P; Muñoz C; Millan MJ Nat Rev Drug Discov; 2010 Aug; 9(8):628-42. PubMed ID: 20577266 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of agomelatine in epilepsy and epileptic complications. Vimala PV; Bhutada PS; Patel FR Med Hypotheses; 2014 Jan; 82(1):105-10. PubMed ID: 24314750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]